Evidence map›Paper›PMID 32884464›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2020

May Measurement Month 2018: blood pressure screening results in Cameroon.

Anastase Dzudie, Epie Njume, Jerome Boombhi, Alexis Awungia, Marie S Ndom, Peter Vanes Ebasone, Armel Djomou A, Hamadou Ba, Liliane K Mfekeu, Alain Menanga and 6 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. May Measurement Month 2019: an analysis of blood pressure screening results from Cameroon.European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anastase DzudieCameroon Cardiac Society, Cameroon.
Epie NjumeClinical Research Education, Networking and Consultancy, PO Box 3480, Douala, Cameroon.
Jerome BoombhiCameroon Cardiac Society, Cameroon.
Alexis AwungiaClinical Research Education, Networking and Consultancy, PO Box 3480, Douala, Cameroon.
Marie S NdomCameroon Cardiac Society, Cameroon.
Peter Vanes EbasoneClinical Research Education, Networking and Consultancy, PO Box 3480, Douala, Cameroon.
Armel Djomou ACameroon Cardiac Society, Cameroon.
Hamadou BaCameroon Cardiac Society, Cameroon.
Liliane K MfekeuCameroon Cardiac Society, Cameroon.
Alain MenangaCameroon Cardiac Society, Cameroon.
Felicite KamdemCameroon Cardiac Society, Cameroon.
Xin XiaImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Anca Chis SterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Samuel KingueCameroon Cardiac Society, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a global public health challenge, but awareness, treatment, and control rates remain low. May Measurement Month (MMM) creates a platform for awareness creation and opportunistic screening which can identify significant numbers with raised blood pressure (BP). We present results of the 2018 edition of MMM in Cameroon. A cross-sectional survey of self-selected volunteers aged ≥18 years was conducted in May 2018. The definition of hypertension and statistical analyses followed the standard protocol. Data were collected from 28 public (indoors and outdoors) and private locations which were assigned unique site identification numbers, over a 30-day period. Of the 8883 participants screened, 53.8% were male and the median age was 35 (interquartile range 21) years, and 30.0% reported not having a previous BP measurement. After imputation, 1867 (21.0%) were hypertensive, 645 (34.5%) were aware of their diagnosis, and 507 (27.2%) were on antihypertensive medication, among whom 242 (47.8%) had controlled BP. In linear regression models adjusting for age, sex, and the use of antihypertensive medication, systolic and diastolic BP were significantly higher in participants aware of their diagnosis, those on antihypertensive medication, and who reported alcohol intake of 1-3 times per month and, one or more times per week. Hypertension prevalence is the lowest, and awareness, treatments, and control rates the highest reported in epidemiological studies in Cameroon in the last two decades. Further surveys will be useful in evaluating the impact, if any, of the MMM campaign on the burden of hypertension in the Cameroon.

Indexed as

Blood pressureControlHypertensionScreeningTreatment

Identifiers

PMID32884464
PMCPMC7455289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.